ʻO MDMA kahi kokoke loa i ka hoʻohana ʻia e mālama iā PTSD

Anter

• Nānā no

Inā ʻoe i lohe e pili ana i ka pāʻina lāʻau ecstasy, hiki iā ʻoe ke hoʻopili aku iā ia me nā raves, nā ʻahamele Phish, a i ʻole nā ​​kalapu hulahula e pāʻani ana i nā bangers a kakahiaka. Akā ua hāʻawi aku ka FDA i ka pūhui psychoactive i ka ecstasy, MDMA, ke kūlana "breakthrough therapy". I kēia manawa i nā pae hope loa o ka hoʻāʻo ʻia ʻana ma ke ʻano he lapaʻau no ka maʻi maʻi post-traumatic stress (PTSD), e like me ka mea i hōʻike ʻia ma kahi hoʻolaha paʻi mai ka Multidisciplinary Association for Psychedelic Studies (MAPS), kahi hui ʻole.

ʻAʻole wale ia ʻano hoʻohālikelike kikoʻī e hoʻomaʻamaʻa maikaʻi ʻo MDMA i nā mea maʻi i nā hoʻokolohua ma mua, akā he maikaʻi loa ia e wikiwiki ʻia kāna pae hope loa o ka hoʻāʻo ʻana. He mea koʻikoʻi no ka lāʻau pāʻina, ʻeā?

"Ma ka hāʻawi ʻana i [MDMA] breakthrough therapy designation, ua ʻae ka FDA e loaʻa paha i kēia lapaʻau ka pono kūpono a me ka hoʻokō ʻana i nā lāʻau lapaʻau i loaʻa no PTSD," wahi a Amy Emerson, ka luna hoʻokele a me ka luna o ka noiʻi lapaʻau ma MAPS. "E hālāwai ana kā mākou me ka FDA ma ka hopena o kēia makahiki-2017-e maopopo maopopo ai pehea mākou e hana pono ai e hōʻoia i ka holo ʻana o ka papahana a ma kahi e loaʻa ai nā hopena kūpono i ka manawa manawa."

He pilikia koʻikoʻi ka PTSD. "Ma kahi o 7 pakeneka o ka heluna kanaka US-a me 11 i ka 17 pakeneka o nā koa koa US-e loaʻa iā PTSD i kekahi manawa i ko lākou ola," wahi a Emerson. A ʻo ka noiʻi i hala e pili ana i ka hoʻohana ʻana i ka psychotherapy kōkua MDMA i nā mea maʻi me PTSD e hemo ana ka iwi: Ke nānā nei i ka poʻe 107 me ka PTSD maʻi mau (17.8 mau makahiki o ka ʻehaʻeha ʻana o kēlā me kēia kanaka), 61 pakeneka ʻaʻole i kūpono hou ma ke ʻano he PTSD ma hope o ʻekolu mau kau o MDMA. - kōkua psychotherapy i ʻelua mahina ma hope o ka mālama ʻana. Ma ka hahai ʻana o 12 mau mahina, 68 pakeneka ʻaʻole loaʻa iā PTSD, e like me MAPS. Akā no ka liʻiliʻi o ka nui o ka laʻana a ma o ʻeono mau noi wale nō, e ʻōlelo ana ʻo Emerson-Phase 3 e hoʻāʻo nei me ka FDA e pono ai e hōʻoia i ka pono o MDMA ma kahi pālākiō nui aʻe.

He mea nui e hoʻomaopopo i ka MDMA e hoʻohana nei kēia mau maʻi i kā lākou mau kau psychotherapy ʻaʻole like me nā mea āu e loaʻa ai ma kahi pāʻina. "ʻO ka MDMA i hoʻohana ʻia no nā haʻawina ʻo 99.99% maʻemaʻe a hana ʻia e hahai i nā koi kānāwai āpau no ka lāʻau lapaʻau," wahi a Emerson. "Hoʻokele pū ʻia ia ma lalo o ka mālama hoʻomalu." ʻO "Molly," ma kekahi ʻaoʻao, ua kūʻai ʻia me ke kānāwai ʻole a hiki ke loaʻa i kahi MDMA liʻiliʻi, me nā mea ʻino ʻē aʻe.

A ʻaʻole like me ka lawe ʻana i ka lāʻau lapaʻau alanui, mālama ʻia ka psychotherapy i kōkua ʻia e MDMA i ʻekolu mau manawa psychotherapy hoʻokahi-dose i hoʻokaʻawale ʻia ʻekolu a ʻelima mau pule. Hoʻopili pū ʻia me ke kākoʻo kaiaulu, me ka noʻonoʻo a me ka hoʻoikaika ʻana i ka hanu. No laila ʻaʻole kūpono kēia i ka lawe ʻana i ka lāʻau pāʻina, ʻoiaʻiʻo ia e hoʻohiki i ka noiʻi no ka poʻe e loaʻa ana i ka PTSD.

Nānā no